RxDoctor Payments Data

Bruce Jackson

Medical · Apple Valley, CANPI 1124072087

Payments from drug & device makers

$1,345in general payments, 2019–2025

Across 63 payments — averaging $21.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$446
  • Lilly USA, LLC$139
  • Biohaven Pharmaceutical Holding Company Ltd.$111
  • Bayer$101
  • Pfizer$85
  • Merck$70
  • plus $393 from 14 others

What the payments were for

  • Food & beverage$1,345100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,345 in reported general payments places this provider in the 65th percentile of 2,087 medical providers in California.

See all medical providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
Omeprazole-Sodium BicarbonateOmeprazole/Sodium Bicarbonate15$37,174
JardianceEmpagliflozin27$22,681
Diclofenac Sodium40$19,131
JanuviaSitagliptin Phosphate16$17,233
EliquisApixaban13$12,648
OzempicSemaglutide13$11,751
XareltoRivaroxaban21$10,823
Atrovent HfaIpratropium Bromide16$7,412
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog18$5,695
Metformin Hcl115$3,971
Fenofibrate13$3,675
Albuterol Sulfate HfaAlbuterol Sulfate60$2,097
Atorvastatin Calcium211$1,710
Nifedipine ErNifedipine33$866
Omeprazole116$820

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$17$22,68127 claims
MerckJanuvia$70$17,23316 claims
PfizerEliquis$85$12,64813 claims
Novo NordiskOzempic$446$11,75113 claims
Johnson & JohnsonXarelto$24$10,82321 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,087 medical providers in California.

Other medical in Apple Valley

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →